Table 2 Patients’characteristics – postoperative patients (n = 87)
Characteristic | n (%) |
|---|---|
Tumor stage | |
pT2a | 6 (6.9) |
pT2b | 4 (4.6) |
pT2c | 15 (17.2) |
pT3a | 20 (23) |
pT3b | 37 (42.5) |
pT4 | 1 (1.1) |
Tx | 4 (4.6) |
pN0 | 54 (62.1) |
pN1 | 30 (34.5) |
pM1a | 3 (3.4) |
R0 | 39 (44.8) |
R1 | 41 (47.1) |
Rx | 7 (8.0) |
Gleason score | |
≤6 | 10 (11.5) |
7 (3 + 4) | 18 (20.7) |
7 (4 + 3) | 16 (18.4) |
8 | 12 (13.8) |
9 | 21 (24.1) |
10 | 1 (1.1) |
missing | 9 (10.3) |
Initial PSA (ng/ml) | |
Mean | 28.7 |
Median | 10.35 |
Range | 1.56–392.00 |
Nadir (postoperative PSA) (ng/ml) | |
Mean | 1.85 |
Median | 0.23 |
Range | 0–32.00 |
PSA at the time of PET/CT (ng/ml) | |
Mean | 6.43 |
Median | 3.12 |
Range | 0.21–56.00 |
Age (years) | |
Mean | 62.4 |
Median | 63 |
Range | 41–82 |
Time from surgery until PET/CT (months) | |
Mean | 48.2 |
Median | 32.0 |
Range | 0–209 |